AstraZeneca said its COVID-19 vaccine is 76 percent effective for preventing symptomatic illness after a new analysis of updated U.S. trial results. It's down from the 79-percent efficacy rate previously announced.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3